Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Regulus Therapeutics Inc. (RGLS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/17/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
04/16/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
01/27/2021 |
4/A
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 793,528 shares
@ $0.6301, valued at
$500k
|
|
05/21/2019 |
4/A
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 370,370 shares
@ $1.08, valued at
$400k
Granted 370,370 warrants
@ $1.08, valued at
$400k
|
|
05/21/2019 |
4/A
| RASTETTER WILLIAM H (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 92,889 shares
@ $1.08, valued at
$100.3k
Granted 92,889 warrants
@ $1.08, valued at
$100.3k
|
|
05/21/2019 |
4/A
| Witz Pascale (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 29,630 shares
@ $1.08, valued at
$32k
Granted 29,630 warrants
@ $1.08, valued at
$32k
|
|
05/21/2019 |
4/A
| Hagan Joseph P (President and CEO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 33,194 shares
@ $1.08, valued at
$35.8k
Granted 33,194 warrants
@ $1.08, valued at
$35.8k
|
|
05/16/2019 |
4/A
| Chevallard Daniel R. (CFO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 8,000 options to buy
@ $0.95, valued at
$7.6k
|
|
05/10/2019 |
4/A
| Walker Paul Edward (10% Owner) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Bought 1,136,704 shares
@ $1.08, valued at
$1.2M
Bought 3,703,704 warrants
@ $1.08, valued at
$4M
Bought 256,700 options to buy
@ $10.8, valued at
$2.8M
|
|
|
|